Penile Rehabilitation (Post-Prostatectomy)
Erectile rehabilitation after radical prostatectomy
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- N/A (protocol using approved agents/devices off-label)
Reference only. Not medical advice.
What can go wrong
Risks derive from the component therapies: PDE5 inhibitor side effects, VED bruising, and injection-related priapism or fibrosis. The principal clinical uncertainty is that high-quality trials have produced mixed results, so men should have realistic expectations about benefit.
This is something to take to a clinician. The Atlas can tell you what is known about penile rehabilitation (post-prostatectomy) in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Penile rehabilitation is the structured use of PDE5 inhibitors, vacuum erection devices, and/or intracavernosal injection after radical prostatectomy to preserve corporal tissue oxygenation and promote nerve recovery during the months when spontaneous erections are absent. The rationale is to prevent hypoxic fibrosis of erectile tissue while the cavernous nerves regenerate. Evidence is growing but the optimal protocol and timing remain debated.
Keeping the tissue alive while the nerves recover.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
What people get wrong
Often saidRehabilitation guarantees you will recover erections
ActuallyOutcomes depend heavily on nerve-sparing status, age, and baseline function. Rehabilitation may improve odds and preserve tissue, but it is not a guarantee, and the evidence is mixed on long-term benefit.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
How we got here
The concept emerged as nerve-sparing radical prostatectomy became standard and clinicians recognized that prolonged post-surgical flaccidity led to corporal fibrosis and length loss. Protocols combining scheduled PDE5 inhibitors, VEDs, and injections were developed through the 2000s.
At a glance
- Rationale
- Tissue oxygenation + nerve recovery
- Guideline stance
- AUA recommends early intervention
- Debate
- Immediate vs delayed timing
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Penile Rehabilitation (Post-Prostatectomy). A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.